Outcomes of patients treated with SVILE vs. P-GemOx for extranodal natural killer/T-cell lymphoma, nasal type: a prospective, randomized controlled study

Objective: To compare the efficacy and safety of the novel SVILE regimen with the P-GemOx regimen in patients with newly diagnosed extranodal natural killer/T-cell lymphoma, nasal type (ND-ENKTL). Methods: From April 2015 to July 2018, 103 patients with ND-ENKTL were randomly assigned to SVILE (expe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Biol Med
Main Authors: Wei, Liqiang, Yang, Lei, Ye, Jin, Cong, Jia, Li, Xin, Yao, Na, Yang, Jing, Cui, Xueying, Ding, Jing, Wu, Yiping, Wang, Jingwen
Formato: Artigo
Idioma:Inglês
Publicado em: Compuscript 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7476087/
https://ncbi.nlm.nih.gov/pubmed/32944407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20892/j.issn.2095-3941.2020.0160
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados